Search results
Making art is a uniquely human act, and one that provides a wellspring of health benefits
The Conversation via Yahoo News· 1 day agoExpressive Instinct,” art is intrinsic to human evolution and history. Just as sports or workouts...
S&P 500 Clinches Third Straight Weekly Gain
The Wall Street Journal· 2 hours agoThe S&P 500 ebbed lower Friday, weighed down by a decline in Nvidia shares, but held onto its third consecutive week of gains. The Nasdaq Composite shed...
Mama June Praises Husband Justin for Helping Her Family amid Hardships: 'Appreciate Him Even More'...
People via Yahoo News· 1 day agoMama June/Instagram Mama June with her family June now confirms to PEOPLE that they still "have not"...
Testosterone for Women? The Benefits & Risks - Sherri McMillan
The Columbian· 3 days agoTestosterone therapy for women: know the risks and benefits and learn if you are an ideal candidate....
You Look Tired. We Can Help. A Men’s Guide to Looking More Alert at Work.
The Wall Street Journal· 2 hours agoJet-lagged? Overworked? Restless sleeper? Bloodshot eyes, dark circles and other signs of fatigue...
Taysha Gene Therapies’ (TSHA) “Buy” Rating Reaffirmed at Chardan Capital
ETF DAILY NEWS· 3 days agoChardan Capital reiterated their buy rating on shares of Taysha Gene Therapies (NASDAQ:TSHA – Free Report) in a report issued on Tuesday morning, Benzinga reports. Chardan Capital currently ...
The Best LED Face Masks To Improve Wrinkles And Acne, According To Dermatologists
Women's Health via AOL· 1 day agoThe best FDA-approved LED light therapy face masks, per dermatologists and editors, have benefits...
OS Therapies Inc. Prices IPO at $4.00 Per Share (OSTX)
ETF DAILY NEWS· 6 days agoOS Therapies Inc. (OSTX) plans to raise $8 million in an initial public offering on Thursday, June 20th, IPO Scoop reports. The company will be issuing 2,000,000 shares at a price of $4.00 per ...
FDA lifts hold on PTC Huntington’s disease trial
BioPharma Dive via Yahoo Finance· 1 day agoThat compares with a 1-point improvement for people who got the UniQure gene therapy, analysts wrote. However, PTC518 didn’t appear to have any impact on...
This little-known biotech stock is primed to surge nearly 50%, Canaccord says
CNBC· 1 day agoPositive data from Intra-Cellular Therapies ' latest study could herald further success for the...
